{{Rsnum
|rsid=1437588
|Gene=NR2F2-AS1
|Chromosome=15
|position=96266553
|Orientation=plus
|GMAF=0.4086
|Gene_s=NR2F2-AS1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 23.4 | 50.5 | 26.1
| HCB | 26.7 | 56.3 | 17.0
| JPT | 26.8 | 52.7 | 20.5
| YRI | 0.0 | 6.2 | 93.8
| ASW | 3.5 | 17.5 | 78.9
| CHB | 26.7 | 56.3 | 17.0
| CHD | 39.4 | 48.1 | 12.5
| GIH | 17.2 | 52.5 | 30.3
| LWK | 1.8 | 12.8 | 85.3
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.6 | 23.7 | 75.6
| TSI | 19.8 | 45.5 | 34.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23793025
  |Trait=Migraine
  |Title=Genome-wide meta-analysis identifies new susceptibility loci for migraine.
  |RiskAllele=
  |Pval=3E-6
  |OR=1.05
  |ORtxt=[1.03-1.08]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}